Form 4 for RMD ResMed|
Accepted 2026-04-02 13:52:28 ET · period of report 2026-04-01 · accession 0000943819-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-02 13:52 | 2026-04-01 | RMD | FARRELL PETER C | Dir | S - Sale | $225.00 | -2,000 | 60.8K | -3% | -$450.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2026-04-01 | S | D | 2,000 | $225.00 | 60,773 | D | — | — | (F1) The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025. |